 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/15/2024 |
$24.13 |
$24.15 |
$22.51 |
$22.92 |
1.56M | | 04/16/2024 |
$22.62 |
$22.84 |
$21.80 |
$21.81 |
1.23M | | 04/17/2024 |
$21.94 |
$22.12 |
$21.44 |
$21.50 |
1.08M | | 04/18/2024 |
$21.37 |
$21.86 |
$21.18 |
$21.32 |
1.15M | | 04/19/2024 |
$21.22 |
$21.63 |
$20.78 |
$21.57 |
1.39M |
|
|
| Intellia Therapeutics is a genome editing company focused on developing therapeutics using CRISPR/Cas9 technology. CRISPR/Cas9, an acronym for Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated 9 (Cas9), is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid (DNA). To realize the transformative potential of CRISPR/Cas9-based technologies, Co. is building a range of genome editing company, by utilizing its modular platform, to advance in vivo and ex vivo therapies for diseases with high unmet need. | |
|
Intellia Therapeutics (NTLA) has the following price history information. Looking back at NTLA historical stock prices for the last five trading days, on April 15, 2024, NTLA opened at $24.13, traded as high as $24.15 and as low as $22.51, and closed at $22.92. Trading volume was a total of 1.56M shares. On April 16, 2024, NTLA opened at $22.62, traded as high as $22.84 and as low as $21.80, and closed at $21.81. Trading volume was a total of 1.23M shares. On April 17, 2024, NTLA opened at $21.94, traded as high as $22.12 and as low as $21.44, and closed at $21.50. Trading volume was a total of 1.08M shares. On April 18, 2024, NTLA opened at $21.37, traded as high as $21.86 and as low as $21.18, and closed at $21.32. Trading volume was a total of 1.15M shares. On April 19, 2024, NTLA opened at $21.22, traded as high as $21.63 and as low as $20.78, and closed at $21.57. Trading volume was a total of 1.39M shares.
NTLA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Intellia Therapeutics shares, starting with a $10,000 purchase of NTLA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/09/2016 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$24.00 |
|
| End price/share: |
$21.57 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-10.12% |
|
| Average Annual Total Return: |
-1.33% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$8,990.17 |
|
| Years: |
7.95 |
|
|
|
| Date |
Close |
| 04/15/2024 | $22.92 | | 04/16/2024 | $21.81 | | 04/17/2024 | $21.50 | | 04/18/2024 | $21.32 | | 04/19/2024 | $21.57 |
|
|
Free NTLA Email Alerts:
